Study of Cemiplimab in Adults With Cervical Cancer

Clinical trial NCT03257267 · COMPLETED

Trial details

NCT number: NCT03257267
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Carcinoma (SCC)Recurrent or Metastatic, Platinum-refractory Cervical Cancer

Start date: 2017-09-05
Primary completion: 2021-03-15
Enrollment: 608

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.